| MDS/MPN-RS-T Justified Inclusion as a Unique Disease Entity? |
|
Best practice & research. Clinical haematology |
Myelodysplastic Syndromes (MDS), Myeloproliferative Neoplasms (MPN) |
| Meta-analysis of the results of haploidentical transplantation in the treatment of aplastic anemia |
|
Annals of Hematology |
Aplastic Anemia |
| Modified Delphi Panel Consensus Recommendations for Management of Severe Aplastic Anemia |
|
Blood Advances |
Aplastic Anemia |
| Modified Delphi panel consensus recommendations for management of severe aplastic anemia |
|
Blood Advances |
Aplastic Anemia |
| Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Molecular Taxonomy of Myelodysplastic Syndromes and its Clinical Implications |
|
Blood |
Myelodysplastic Syndromes (MDS) |
| Monitoring and treatment of MDS in genetically susceptible persons |
|
Hematology. American Society of Hematology. Education Program |
Myelodysplastic Syndromes (MDS) |
| Morphologic Characteristics of Myelodysplastic Syndromes |
|
Clinics in Laboratory Medicine |
Myelodysplastic Syndromes (MDS) |
| Multicenter evaluation of the addition of eltrombopag to immunosuppressive therapy for adults with severe aplastic anemia |
|
International Journal of Hematology |
Aplastic Anemia |
